analyst
PR
NASDAQ · PRME
Prime Medicine, Inc.
Healthcare · Biotechnology
$4.55
Up+$0.53 (+11.58%)
Updated Nov 4, 2026, 6:57 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 754.01M
- P/E ratio
- -3.46
- Dividend yield
- 0.00%
- 52-week range
- $2.67 – $5.91
- Volume
- 4.13M
- Avg. volume
- 3.98M
Price performance · PRME
PRME price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
PRME closed at $4.55 after 21 trading sessions, up 30.00% for the selected period.
- Last close
- $4.55
- Period change
- +30.00%
- Period low
- $3.13
- Period high
- $5.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $4.50 | $4.885 | $4.435 | $4.55 | 4.13M |
| Nov 2, 2026 | $4.86 | $4.86 | $4.3606 | $4.44 | 4.12M |
| Oct 30, 2026 | $5.02 | $5.20 | $4.675 | $4.72 | 6.57M |
| Oct 29, 2026 | $5.29 | $5.9099 | $5.19 | $5.24 | 10.35M |
| Oct 28, 2026 | $4.24 | $5.43 | $4.11 | $5.36 | 15.2M |
| Oct 27, 2026 | $3.62 | $4.4095 | $3.57 | $4.35 | 8.82M |
| Oct 26, 2026 | $3.68 | $3.70 | $3.57 | $3.61 | 2.51M |
| Oct 23, 2026 | $3.70 | $3.70 | $3.38 | $3.67 | 4.56M |
| Oct 22, 2026 | $3.68 | $3.9199 | $3.62 | $3.73 | 4.66M |
| Oct 21, 2026 | $3.92 | $4.005 | $3.795 | $3.81 | 2.44M |
| Oct 20, 2026 | $3.75 | $4.05 | $3.73 | $3.92 | 3.69M |
| Oct 19, 2026 | $3.56 | $3.87 | $3.49 | $3.83 | 4.25M |
| Oct 16, 2026 | $3.55 | $3.605 | $3.41 | $3.47 | 4.39M |
| Oct 15, 2026 | $3.12 | $3.65 | $3.06 | $3.61 | 6.3M |
| Oct 14, 2026 | $3.21 | $3.22 | $3.045 | $3.13 | 4.24M |
| Oct 13, 2026 | $3.61 | $3.61 | $3.27 | $3.32 | 4.06M |
| Oct 12, 2026 | $3.95 | $3.965 | $3.58 | $3.61 | 3.14M |
| Oct 9, 2026 | $3.57 | $4.14 | $3.54 | $3.99 | 8.07M |
| Oct 8, 2026 | $3.83 | $3.8984 | $3.52 | $3.58 | 7.73M |
| Oct 7, 2026 | $3.36 | $4.02 | $3.3001 | $3.90 | 11.2M |
| Oct 6, 2026 | $3.56 | $3.7176 | $3.26 | $3.50 | 12.02M |
Latest PRME news
The latest Smart Investors Daily articles mentioning PRME.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…

